- Release Date: 13/03/23 09:10
- Summary: FDA approves Daybue - the first treatment for Rett syndrome
- Price Sensitive: Yes
- Download Document 258.83KB
Ann: FDA approves Daybue - the first treatment for Rett syndrome
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
$17.76 |
Change
0.210(1.20%) |
Mkt cap ! $2.199B | |||
| Open | High | Low | Value | Volume |
| $17.83 | $17.99 | $17.35 | $12.56M | 712.2K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 687 | $17.75 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $17.78 | 600 | 1 |
View Market Depth
| Last trade - 15.35pm 08/08/2025 (20 minute delay) ? |
| NEU (ASX) Chart |